🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and claims of rapid British shipping. Vendors promote the substance there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Experts Express Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could result in users injecting products of uncertain source.

Several professionals said the demand for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach pharmaceutical, advertising, and customer regulations, risking penalties, legal action or imprisonment.

Service Reaction and Content Elimination

According to TikTok, the service has removed problematic content and prohibited associated keywords and query recommendations. The company said it was committed to keeping the platform secure and investing in enhancing compliance measures.

Online Marketplace Operations

Investigations also discovered communities with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, filled with photos of slimming results, positive testimonials and detailed instructions for preparing or injecting at home.

After moments of joining one community, a seller shared WhatsApp details, where most transactions occur. The seller sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.

Product Information and Pricing

Within these groups, posts show dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service stated it regularly monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they cannot confirm. Although the research behind retatrutide is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.

Her staff has previously encountered individuals harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational product not yet authorized … may expose users to possibly serious medical dangers”.